$AQU
Aquaron Acquisition Corp. Stock $aqu

$aqu Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000121390024098561 Filed on November 14, 2024

Income Statement

Concept	2024 Q4	2024 Q3
Revenue		$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin		$351.5K
YoY Change		170.35%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses		$351.5K
YoY Change		170.35%
Operating Profit		-$351.4K
YoY Change		175.81%
Interest Expense		$116.4K
YoY Change		-74.13%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income		-$235.0K
YoY Change		-173.45%
Income Tax		$22.61K
% Of Pretax Income
Net Earnings		-$257.7K
YoY Change		-201.73%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share		-$0.11
COMMON SHARES
Basic Shares Outstanding	2.428M shares	4.553M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q4	2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments		$109.7K
YoY Change		-99.65%
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets		$165.0K
YoY Change		-8.34%
Inventory
Prepaid Expenses		$20.25K
Receivables
Other Receivables
Total Short-Term Assets		$274.6K
YoY Change		-99.13%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments		$9.110M
YoY Change
Other Assets
YoY Change
Total Long-Term Assets		$9.110M
YoY Change
TOTAL ASSETS
Total Short-Term Assets		$274.6K
Total Long-Term Assets		$9.110M
Total Assets		$9.384M
YoY Change		-70.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable		$384.0K
YoY Change		91.99%
Accrued Expenses		$22.30K
YoY Change		-25.67%
Deferred Revenue
YoY Change
Short-Term Debt		$1.650M
YoY Change		117.06%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities		$2.706M
YoY Change		-33.48%
LONG-TERM LIABILITIES
Long-Term Debt		$0.00
YoY Change
Other Long-Term Liabilities		$2.526M
YoY Change
Total Long-Term Liabilities		$2.526M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities		$2.706M
Total Long-Term Liabilities		$2.526M
Total Liabilities		$5.232M
YoY Change		28.61%
SHAREHOLDERS EQUITY
Retained Earnings		-$4.957M
YoY Change		27.81%
Common Stock		$163.00
YoY Change		0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity		-$4.957M
YoY Change
Total Liabilities & Shareholders Equity		$9.384M
YoY Change		-70.16%

Cashflow Statement

Concept	2024 Q4	2024 Q3
OPERATING ACTIVITIES
Net Income		-$257.7K
YoY Change		-201.73%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities		-$130.8K
YoY Change		86.89%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities		-$80.00K
YoY Change		-100.31%
Cash From Investing Activities		-$80.00K
YoY Change		-100.31%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		109.0K
YoY Change		-100.42%
NET CHANGE
Cash From Operating Activities		-130.8K
Cash From Investing Activities		-80.00K
Cash From Financing Activities		109.0K
Net Change In Cash		-101.8K
YoY Change		69.7%
FREE CASH FLOW
Cash From Operating Activities		-$130.8K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
	dei	Entity Registrant Name EntityRegistrantName	AQUARON ACQUISITION CORP.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity File Number EntityFileNumber	001-41470
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	86-2760193
	dei	Entity Address Address Line2 EntityAddressAddressLine2	8th Floor
CY2023Q3	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	675207	usd
	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	326456	usd
	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	9633966	usd
CY2024Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity Address Address Line1 EntityAddressAddressLine1	515 Madison Avenue
	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10022
	dei	City Area Code CityAreaCode	(646)
	dei	Local Phone Number LocalPhoneNumber	970 2181
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	No
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	true
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	2428412	shares
CY2024Q3	us-gaap	Cash Cash	109650	usd
CY2023Q4	us-gaap	Cash Cash	339	usd
CY2024Q3	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	144736	usd
CY2024Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	20250	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2188	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	274636	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	2527	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	144680	usd
CY2024Q3	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	9109815	usd
CY2023Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	31960267	usd
CY2024Q3	us-gaap	Assets Noncurrent AssetsNoncurrent	9109815	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	32104947	usd
CY2024Q3	us-gaap	Assets Assets	9384451	usd
CY2023Q4	us-gaap	Assets Assets	32107474	usd
CY2024Q3	aqu	Other Payable Related Party OtherPayableRelatedParty	138665	usd
CY2023Q4	aqu	Other Payable Related Party OtherPayableRelatedParty	97052	usd
CY2024Q3	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	20000	usd
CY2024Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	383967	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	149045	usd
CY2024Q3	aqu	Franchise Tax Payable FranchiseTaxPayable	22300	usd
CY2023Q4	aqu	Franchise Tax Payable FranchiseTaxPayable	18495	usd
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	353013	usd
CY2024Q3	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	491207	usd
CY2023Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	259438	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	2705765	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1916669	usd
CY2024Q3	aqu	Deferred Underwriting Fee Payable Non Current DeferredUnderwritingFeePayableNonCurrent	2525896	usd
CY2023Q4	aqu	Deferred Underwriting Fee Payable Non Current DeferredUnderwritingFeePayableNonCurrent	2525896	usd
CY2024Q3	us-gaap	Liabilities Liabilities	5231661	usd
CY2023Q4	us-gaap	Liabilities Liabilities	4442565	usd
CY2024Q3	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	0.0001
CY2023Q4	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	0.0001
CY2024Q3	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	10000000	shares
CY2024Q3	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	805352	shares
CY2024Q3	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	805352	shares
CY2023Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	2930090	shares
CY2023Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	2930090	shares
CY2024Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	9109815	usd
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	31960268	usd
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000	shares
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1623060	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1623060	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1623060	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1623060	shares
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	163	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	163	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-4957188	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-4295522	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	-4957025	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-4295359	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	9384451	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	32107474	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	345648	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	117125	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	545126	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	718439	usd
CY2024Q3	us-gaap	Franchisor Costs FranchisorCosts	5800	usd
CY2023Q3	us-gaap	Franchisor Costs FranchisorCosts	10300	usd
	us-gaap	Franchisor Costs FranchisorCosts	22300	usd
	us-gaap	Franchisor Costs FranchisorCosts	34400	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-351448	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-127425	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-567426	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-752839	usd
CY2024Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	116923	usd
CY2023Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	548881	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	752116	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	1569987	usd
CY2024Q3	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-519	usd
CY2023Q3	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-100867	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	37433	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	133387	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-235044	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	320589	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	222123	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	950535	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	22612	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	91920	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	180914	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	349036	usd
CY2023Q3	aqu	Deferred Income Tax Benefit DeferredIncomeTaxBenefit	-24596	usd
	aqu	Deferred Income Tax Benefit DeferredIncomeTaxBenefit	144680	usd
	aqu	Deferred Income Tax Benefit DeferredIncomeTaxBenefit	-114673	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-257656	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	253265	usd
	us-gaap	Net Income Loss NetIncomeLoss	-103471	usd
	us-gaap	Net Income Loss NetIncomeLoss	716172	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-4295359	usd
CY2024Q1	aqu	Accretion Of Common Stock To Redemption Value AccretionOfCommonStockToRedemptionValue	-532235	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	98814	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-4728780	usd
CY2024Q2	aqu	Accretion Of Common Stock To Redemption Value AccretionOfCommonStockToRedemptionValue	402213	usd
CY2024Q2	aqu	Excise Tax Liability ExciseTaxLiability	-231769	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	55371	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-4502965	usd
CY2024Q3	aqu	Accretion Of Common Stock To Redemption Value AccretionOfCommonStockToRedemptionValue	-196404	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-257656	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	-4957025	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	5298740	usd
CY2023Q1	aqu	Accretion Of Common Stock To Redemption Value AccretionOfCommonStockToRedemptionValue	-4135212	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	151806	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	1315334	usd
CY2023Q2	aqu	Accretion Of Common Stock To Redemption Value AccretionOfCommonStockToRedemptionValue	-4823546	usd
CY2023Q2	aqu	Excise Tax Liability ExciseTaxLiability	-259438	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	311101	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-3456549	usd
CY2023Q3	aqu	Accretion Of Common Stock To Redemption Value AccretionOfCommonStockToRedemptionValue	-675207	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	253265	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-3878491	usd
	us-gaap	Net Income Loss NetIncomeLoss	-103471	usd
	us-gaap	Net Income Loss NetIncomeLoss	716172	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	752116	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	1569987	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	37433	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	133387	usd
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-144680	usd
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	114673	usd
	us-gaap	Increase Decrease In Due To Other Related Parties IncreaseDecreaseInDueToOtherRelatedParties	138665	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	20000	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	18062	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-151500	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	234922	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	61102	usd
	aqu	Increase Decrease In Franchise Tax Payable IncreaseDecreaseInFranchiseTaxPayable	3805	usd
	aqu	Increase Decrease In Franchise Tax Payable IncreaseDecreaseInFranchiseTaxPayable	13493	usd
	us-gaap	Increase Decrease In Income Taxes IncreaseDecreaseInIncomeTaxes	-497749	usd
	us-gaap	Increase Decrease In Income Taxes IncreaseDecreaseInIncomeTaxes	323156	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-866759	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-552624	usd
	aqu	Cash Deposited Into Trust Account CashDepositedIntoTrustAccount	330000	usd
	aqu	Cash Deposited Into Trust Account CashDepositedIntoTrustAccount	210000	usd
	aqu	Proceeds From Cash Withdrawn From Trust Account To Pay Taxes ProceedsFromCashWithdrawnFromTrustAccountToPayTaxes	793122	usd
	aqu	Proceeds From Cash Withdrawn From Trust Account To Pay Taxes ProceedsFromCashWithdrawnFromTrustAccountToPayTaxes	129175	usd
	aqu	Cash Withdrawn From Trust Account For Public Stockholder Redemption CashWithdrawnFromTrustAccountForPublicStockholderRedemption	23176909	usd
	aqu	Cash Withdrawn From Trust Account For Public Stockholder Redemption CashWithdrawnFromTrustAccountForPublicStockholderRedemption	25943774	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	23640031	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	25862949	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	202948	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	370000	usd
	aqu	Proceeds From Promissory Note Bestpath ProceedsFromPromissoryNoteBestpath	270000	usd
	aqu	Proceeds From Promissory Note Bestpath ProceedsFromPromissoryNoteBestpath	210000	usd
	aqu	Proceeds From Promissory Note Huture ProceedsFromPromissoryNoteHuture	40000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	23176909	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	25943774	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-22663961	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-25363774	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	109311	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-53449	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	339	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	57284	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	109650	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3835	usd
	aqu	Accretion Of Common Stock To Redemption Values AccretionOfCommonStockToRedemptionValues	326456	usd
	aqu	Accretion Of Common Stock To Redemption Values AccretionOfCommonStockToRedemptionValues	9633966	usd
	aqu	Excise Tax Payable Charged Against Retained Earnings ExciseTaxPayableChargedAgainstRetainedEarnings	231769	usd
	aqu	Excise Tax Payable Charged Against Retained Earnings ExciseTaxPayableChargedAgainstRetainedEarnings	259438	usd
	us-gaap	Stock Issued1 StockIssued1	79780	usd
	us-gaap	Notes Issued1 NotesIssued1	97052	usd
	us-gaap	Notes Issued1 NotesIssued1	99846	usd
	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	2021-03-11
	aqu	Grantedthe Underwritera Optionto Purchase Period GrantedtheUnderwriteraOptiontoPurchasePeriod	P45D
	aqu	Term Of Investment Maturity TermOfInvestmentMaturity	P185D
	aqu	Aggregate Fair Market Value AggregateFairMarketValue	0.80	pure
	aqu	Agreement Percentage AgreementPercentage	0.80	pure
	aqu	Trust Account Balance TrustAccountBalance	0.80	pure
	aqu	Percentage Obligation To Redeem Public Shares If Entity Does Not Complete Business Combination PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination	1	pure
CY2024Q3	us-gaap	Equity Fair Value Disclosure EquityFairValueDisclosure	1000000000	usd
CY2023Q2	us-gaap	Deposits Deposits	70000	usd
	us-gaap	Temporary Equity Stock Issued During Period Value New Issues TemporaryEquityStockIssuedDuringPeriodValueNewIssues	2487090	usd
CY2024Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	70000	usd
CY2024Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	20000	usd
CY2024Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	20000	usd
CY2024Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	20000	usd
CY2024Q4	us-gaap	Notes Payable NotesPayable	20000	usd
CY2024Q4	us-gaap	Notes Payable NotesPayable	20000	usd
CY2024Q3	aqu	Aggregate Shares Redemption AggregateSharesRedemption	2124738	shares
CY2024Q3	aqu	Share Redemption Value ShareRedemptionValue	23176909	usd
	aqu	Redemption Price Per Share RedemptionPricePerShare	10.91
	aqu	Interestto Pay Dissolution Expenses InteresttoPayDissolutionExpenses	50000	usd
CY2024Q3	aqu	Remaining Price Per Share RemainingPricePerShare	10.15
	aqu	Trust Account Per Share TrustAccountPerShare	10.15
CY2024Q3	us-gaap	Cash Cash	109650	usd
CY2024Q3	aqu	Working Capital Deficit WorkingCapitalDeficit	2431129	usd
	aqu	Payment From Sponsor PaymentFromSponsor	25000	usd
CY2024Q3	us-gaap	Notes Payable NotesPayable	300000	usd
CY2022Q4	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	300000	usd
CY2023Q4	us-gaap	Loans Payable LoansPayable	449780	usd
CY2024Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	200000	usd
CY2024Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	200000	usd
CY2023Q4	aqu	Conversion Outstanding ConversionOutstanding	97052	usd
CY2023	aqu	Transaction Cost TransactionCost	100000	usd
CY2022Q3	us-gaap	Derivative Average Forward Interest Rate DerivativeAverageForwardInterestRate	0.01	pure
CY2022Q3	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Other EffectiveIncomeTaxRateReconciliationTaxCreditsOther	0.01	pure
CY2023	us-gaap	Excise And Sales Taxes ExciseAndSalesTaxes	259438	usd
	us-gaap	Excise And Sales Taxes ExciseAndSalesTaxes	231769	usd
CY2024Q3	us-gaap	Sales And Excise Tax Payable Current And Noncurrent SalesAndExciseTaxPayableCurrentAndNoncurrent	491207	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Use of Estimates</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In preparing these unaudited financial statements in conformity with U.S. GAAP, the Company’s management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported expenses during the reporting period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2024Q3	us-gaap	Cash Cash	109650	usd
CY2023Q4	us-gaap	Cash Cash	339	usd
CY2024Q3	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	9109815	usd
CY2023Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	31960267	usd
	aqu	Interests Earned Fromthe Trust Account InterestsEarnedFromtheTrustAccount	789549	usd
	aqu	Interests Earned Fromthe Trust Account InterestsEarnedFromtheTrustAccount	1703374	usd
CY2024Q3	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	-0.0962	pure
CY2023Q3	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	0.2609	pure
	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	1.4654	pure
	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	0.2466	pure
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2024Q3	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023Q3	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2024Q3	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	28258	usd
	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	233626	usd
CY2024Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	243409	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	174157	usd
CY2024Q3	aqu	Deferred Tax Assets Tax Amortization Of Startup Cost DeferredTaxAssetsTaxAmortizationOfStartupCost	5069	usd
CY2023Q4	aqu	Deferred Tax Assets Tax Amortization Of Startup Cost DeferredTaxAssetsTaxAmortizationOfStartupCost	2897	usd
CY2024Q3	us-gaap	Deferred Tax Liabilities Unrealized Gains On Trading Securities DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities	7861	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Unrealized Gains On Trading Securities DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities	29727	usd
CY2024Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	230479	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	141533	usd
CY2024Q3	aqu	Valuation Allowance ValuationAllowance	230479	usd
CY2023Q4	aqu	Valuation Allowance ValuationAllowance	-3147	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	144680	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-257656	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	253265	usd
	us-gaap	Net Income Loss NetIncomeLoss	-103471	usd
	us-gaap	Net Income Loss NetIncomeLoss	716172	usd
CY2024Q3	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	196404	usd
CY2024Q3	aqu	Net Loss Including Accretion Of Common Stock To Redemption Value NetLossIncludingAccretionOfCommonStockToRedemptionValue	-454060	usd
CY2023Q3	aqu	Net Loss Including Accretion Of Common Stock To Redemption Value NetLossIncludingAccretionOfCommonStockToRedemptionValue	-421942	usd
	aqu	Net Loss Including Accretion Of Common Stock To Redemption Value NetLossIncludingAccretionOfCommonStockToRedemptionValue	-429927	usd
	aqu	Net Loss Including Accretion Of Common Stock To Redemption Value NetLossIncludingAccretionOfCommonStockToRedemptionValue	-8917794	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Concentration of Credit Risk</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. As of September 30, 2024 and December 31, 2023, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</p>
	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	250000	usd
	aqu	Common Stock Subject To Possible Redemption CommonStockSubjectToPossibleRedemption	326456	usd
CY2021Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	25000	usd
CY2021Q2	aqu	Share Issued And Outstanding Percentage ShareIssuedAndOutstandingPercentage	0.20	pure
	aqu	Subject To Certain Limited Exceptions Percentage SubjectToCertainLimitedExceptionsPercentage	0.50	pure
	aqu	Trading Day Period Commencing Threshold TradingDayPeriodCommencingThreshold	P20D
	aqu	Trading Day Period Commencing After The Business Combination TradingDayPeriodCommencingAfterTheBusinessCombination	P30D
CY2023Q2	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	99846	usd
CY2024Q1	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	97052	usd
CY2024Q3	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	138665	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	97052	usd
	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	97052	usd
CY2024Q2	us-gaap	Notes Payable NotesPayable	20000	usd
CY2024Q2	us-gaap	Notes Payable NotesPayable	20000	usd
CY2024Q3	us-gaap	Notes Payable NotesPayable	20000	usd
	us-gaap	Shortterm Debt Average Outstanding Amount ShorttermDebtAverageOutstandingAmount	760000	usd
CY2023	us-gaap	Shortterm Debt Average Outstanding Amount ShorttermDebtAverageOutstandingAmount	490000	usd
CY2024Q3	us-gaap	Deposits Deposits	20000	usd
CY2024Q3	us-gaap	Deposits Deposits	20000	usd
CY2024Q3	us-gaap	Deposits Deposits	20000	usd
	aqu	Underwriter Cash Discount UnderwriterCashDiscount	812577	usd
	aqu	Deferred Fee Per Units DeferredFeePerUnits	0.035	pure
	aqu	Deferred Underwriting Commissions Payable DeferredUnderwritingCommissionsPayable	1896013	usd
CY2022Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	100	usd
CY2024Q3	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	9109815	usd
CY2023Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	31960267	usd
CY2024Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable		usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent		usd
CY2024Q3	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent		usd
CY2024Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock		usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock		usd
CY2024Q3	aqu	Deferred Income Tax Benefit DeferredIncomeTaxBenefit		usd
	us-gaap	Increase Decrease In Due To Other Related Parties IncreaseDecreaseInDueToOtherRelatedParties		usd
	aqu	Proceeds From Promissory Note Huture ProceedsFromPromissoryNoteHuture		usd
	us-gaap	Stock Issued1 StockIssued1		usd
CY2024Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue		usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001861063

Files In Submission

Name	View Source	Status
0001213900-24-098561-index-headers.html	Edgar Link	pending
0001213900-24-098561-index.html	Edgar Link	pending
0001213900-24-098561.txt	Edgar Link	pending
0001213900-24-098561-xbrl.zip	Edgar Link	pending
aqu-20240930.xsd	Edgar Link	pending
ea0220465-10q_aquaron.htm	Edgar Link	pending
ea022046501ex31-1_aquaron.htm	Edgar Link	pending
ea022046501ex31-2_aquaron.htm	Edgar Link	pending
ea022046501ex32-1_aquaron.htm	Edgar Link	pending
ea022046501ex32-2_aquaron.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
aqu-20240930_def.xml	Edgar Link	unprocessable
aqu-20240930_lab.xml	Edgar Link	unprocessable
aqu-20240930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ea0220465-10q_aquaron_htm.xml	Edgar Link	completed
aqu-20240930_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AQU
Aquaron Acquisition Corp. Stock $aqu

2024 Q4 Form 10-Q Financial Statement

#000121390024098561 Filed on November 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AQU Aquaron Acquisition Corp. Stock $aqu

2024 Q4 Form 10-Q Financial Statement

#000121390024098561 Filed on November 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AQU
Aquaron Acquisition Corp. Stock $aqu